BRIEF-Citadel Advisors Reports 6.4% Passive Stake In Atara Biotherapeutics As Of March 8

BRIEF-Citadel Advisors Reports 6.4% Passive Stake In Atara Biotherapeutics As Of March 8 - SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Citadel Advisors Reports 6.4% Passive Stake In Atara Biotherapeutics As Of March 8 - SEC Filing

Mar 18, 2024 1:40 PM

March 18 (Reuters) - Atara Biotherapeutics Inc ( ATRA ):

* CITADEL ADVISORS LLC REPORTS 6.4% PASSIVE STAKE IN ATARA

BIOTHERAPEUTICS INC AS OF MARCH 8 - SEC FILING

Source text for Eikon:

Further company coverage:

Previous page： Market Chatter: Microsoft-Backed OpenAI in Late-Stage Negotiations to Purchase Electricity From Helion Energy Next page： Why Is Ondas Stock Soaring Monday?

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Market Chatter: Microsoft-Backed OpenAI in Late-Stage Negotiations to Purchase Electricity From Helion Energy

Mar 23, 2026

01:26 PM EDT, 03/23/2026 (MT Newswires) -- Microsoft ( MSFT )-backed (MSFT) OpenAI is in late-stage negotiations to purchase electricity from fusion startup Helion Energy, Axios reported Monday, citing a person familiar with the situation. The artificial intelligence firm could initially secure 12.5% of the startup's energy output, with plans to reach 5 gigawatts of capacity by 2030 and expand...

Why Is Ondas Stock Soaring Monday?

Mar 23, 2026

Ondas Inc ( ONDS ). shares are trading higher after the company reported fourth-quarter results and disclosed an acquisition. Earnings Snapshot The company reported losses of 36 cents per share, missing the analyst consensus loss of five cents. Sales of $30.1 million beat the consensus estimate of $27.6 million. Revenue surged 198% sequentially to $30.1 million for the quarter ended December 31, 2025, up from $10.1...

Why Are Shares Of Wellgistics Health Falling?

Mar 23, 2026

Shares of Wellgistics Health, Inc. ( WGRX ) are trading lower after the company announced it entered into non-exclusive, non-binding letter of intent to evaluate a potential acquisition of Neuritek Therapeutics. Wellgistics Health ( WGRX ) stock is taking a hit today. Why is WGRX stock dropping? $105 Million Acquisition Would Expand Prescription Fulfillment Abilities Despite the positive news, investors...

--Apollo, Bain Among Private-Equity Bidders for Continental's Industrial Unit, Bloomberg Reports

Mar 23, 2026

01:25 PM EDT, 03/23/2026 (MT Newswires) -- Price: 111.96, Change: -0.04, Percent Change: -0.03 ...